期刊文献+

肺炎支原体肺炎的再认识——从发病机制到临床治疗的探讨 被引量:97

Re-cognition of mycoplasma pneumoniae pneumonia-study about the pathogenesis and clinical management
原文传递
导出
摘要 肺炎支原体(mycoplasma pneumoniae,MP)是儿童社区获得性呼吸道感染的重要病原。传统观念认为,MP感染呈自限性经过,但近年来在临床实践中发现重症MP肺炎明显增多,治疗效果显著下降。目前治疗中的困境与MP肺炎复杂的发病机制有关。本文就目前对MP肺炎发病机制的研究现状及其治疗对策作一探讨。
作者 陈志敏
出处 《中国实用儿科杂志》 CSCD 北大核心 2012年第4期253-257,共5页 Chinese Journal of Practical Pediatrics
关键词 肺炎支原体 肺炎 发病机制 治疗 mycoplasma pneumoniae pneumonia pathogenesis treatment
  • 相关文献

参考文献29

  • 1Waites KB. What's new in diagnostic testing and treatment approaches for Mycoplasma pneumoniae infections in children[J]? Adv Exp Med Biol, 2011,719:47-57.
  • 2张冰,陈志敏.2000-2006年杭州市三岁以上儿童肺炎支原体肺炎临床特征变化趋势[J].中华儿科杂志,2010,48(7):531-534. 被引量:145
  • 3Okazaki N, Ohya H, Sasaki T. Mycoplasma pneumoniae isolated from patients with respiratory infection in Kanagawa Prefecture in 1976-2006: emergence of macrolide-resistantstrains[J]. Jpn J Infect Dis, 2007,60(5) :325-326.
  • 4Morozumi M, Takahashi T, Ubukata K. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia [J]. J Infect Chemother, 2010 , 16(2) :78-86.
  • 5Xin D, Mi Z, Han X, et al. Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China [J ]. Antimicrob Agents Chemother, 2009 , 53 (5) : 2158-2159.
  • 6Liu Y, Ye X, Zhang H, et al. Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China [J]. Antimicrob Agents Chemother, 2009,53(5) :2160-2162.
  • 7Sun G, Xu X, Wang Y, et al. Mycoplasma pneumoniae infection induces reactive oxygen species and DNA damage in A549 human lung carcinoma cells [J ]. Infect Immun, 2008 , 76 (10) : 4405-4413.
  • 8Kannan TR, Baseman JB. ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens [J]. Proc Natl Acad Sci U S A, 2006 , 103 (17) :6724-6729.
  • 9Hardy RD, Coalson JJ, Peters J, et al. Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Myeoplasma pneumoniae CARDS toxin [J]. PLoS One, 2009 , 4(10) : 7562.
  • 10Muir MT, Cohn SM, Louden C, et al. Novel toxin assays implicate Mycoplasma pneumoniae in prolonged ventilator course and hypoxemia[J]. Chest,2011 , 139(2) : 305-310.

二级参考文献34

  • 1韩旭,辛德莉.肺炎支原体对大环内酯类抗生素的耐药机制[J].实用儿科临床杂志,2006,21(16):1101-1103. 被引量:47
  • 2曲政海.感染性肺炎的诊断与治疗[J].实用儿科临床杂志,2007,22(10):731-733. 被引量:19
  • 3陆权,车大钿.肺炎支原体感染诊治中的若干问题[J].国际儿科学杂志,2007,34(4):235-238. 被引量:60
  • 4Korppi M,Heiskanen-Kosma T,Kleemola M.Incidence of community-acquired pneumonia in children caused by Mycoplasna pneumoniae:serological results of a prospective,population-based study in primary health care.Respirology,2004,9:109-114.
  • 5Principi N,Esposito S.Mycoplasma pneumoniae and Chlamydia pneumoniae cause lower respiratory tract disease in paediatric patients.Curr Opin Infect Dis,2002,15:295-300.
  • 6Suzuki S,Yamazaki T,Narita M,et al.Clinical evahuation of macrolide-resistant Mycoplasma pneumoniae Antimicrob Aggents Chemother,2006,50:709-712.
  • 7Bebear CM,Pereyre S.Mechanisms of drug resistance in Mycoplasma pneumoniae Curr Drug Targets Infect Disord,2005,5:263-271.
  • 8Matsuoka M,Narita M,Olazaki N,et al.Charscterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan.Antimicrob Agents Chemother,2004,48:4624-4630.
  • 9Lee KY,lee HS,Hong JH,et al.Role of prednisone treatment in severe Mycoplasma pneumoniae in children.Pediatr Pulmonol,2006,41:263-268.
  • 10Okazaki N,Narita M,Yamada S,et al.Characteristics of macrolide-resistant Mycoplasma pneumoniae strnins isolated from patients and induced with erythhromycin in vitro.Microbiol Immunol,2001,45:617-620.

共引文献301

同被引文献841

引证文献97

二级引证文献902

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部